AbbVie's $175 Million Gamble Pays Off as Ablynx RA Drug Meets Goal in Phase II Study

By Sam | July 8, 2016

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-breaking-news-clinical.jpg" NAME"AbbVie's $175 Million Gamble Pays Off as Ablynx RA Drug Meets Goal in Phase II Study" ALT"AbbVie's $175 Million Gamble Pays Off as Ablynx RA Drug Meets Goal in Phase II Study"July 8, 2016By Alex Keown</A…
Source: BioSpace